By Josh White
Date: Monday 09 Jun 2025
(Sharecast News) - Tissue Regenix announced on Monday that it has received CE and UKCA certifications for its OrthoPure XT biological tendon replacement device, securing continued access to key European and UK medical device markets.
The AIM-traded firm said the certifications, awarded under the updated EU Medical Device Regulation (EU MDR)...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news